Thank you for your interest and support for LitePharmTech.<br> We conduct innovative research and develop the next generation photosensitizer for photodynamic diagnosis and therapy to become a leading pharmaceutical company aims for generalization of treatment skills and early cancer diagnosis by supplying photosensitizers including Photofrin® and medical devices mainly at university hospitals.

Photofrin® is a future generation of cancer treatment product preserves important functions of the organs. Photofrin®, currently, is being prescribed in nationwide university hospitals as a treatment option for lung cancer, esophageal cancer, bile duct cancer etc., as a future generation of cancer therapy.
Additionally, MultiBlue 5 injection, Zinctrace injection and Selinu Injection, Luthione Injection, Lipodetox Injection, Litezinc syrup are the first domestically are the first domestically produced anti-oxidant injections developed by our company that enhance immunity through their strong anti-oxidant power and these are actively prescribed to all sorts of virus and diseases and given to critically ill patient or patients after surgeries. Also, we expand our business to Ophthalmic Solution area to support medical treatment of Ophthalmic disease

With the motto of company ‘We never stop until we accomplished!!', LitePharmTech Co. Ltd will be growing to be a world famous biomedical company contributes to healthy world without any pain from diseases by working on ‘early diagnosis of cancer and therapeutic materials’ and ‘anti-aging medicine’. Sincerely,

Kim Jung Sook/ C.E.O LitePharmTech Co. Ltd.